# Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma

> **NCT05044676** · — · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 4 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** patients with hepatocellular carcinoma

## Key facts

- **NCT ID:** NCT05044676
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-08
- **Primary completion:** 2025-09-22
- **Final completion:** 2025-09-22
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Abandon of study
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05044676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05044676, "Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05044676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*